Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.
Here’s how HIV funding from the CARES Act gets divided
During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed.
However, Latinos are still less likely to have coverage compared with whites.
Fact-checkers and HIV advocates break down the president’s State of the Union boasts.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
But that doesn’t mean the Affordable Care Act is safe. Here’s what’s up next.
Beginning January 1, pharmacists can provide an initial supply of the pills that prevent HIV.
Data from 2018 show a record low number of new HIV cases and a huge increase in people taking PrEP.
Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.
The court case could eliminate protections for people with pre-existing conditions. Plus 20 million Americans could lose their insurance.
A new analysis finds that Obamacare has driven down the proportion of individuals without insurance.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
The Department of Justice seeks to throw out the Affordable Care Act entirely.
These two men both recently discovered that they had hepatitis C, each with a different story about their encounters with insurance.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.